prazosin has been researched along with Duodenal Obstruction in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Duodenal Obstruction: Hindrance of the passage of luminal contents in the DUODENUM. Duodenal obstruction can be partial or complete, and caused by intrinsic or extrinsic factors. Simple obstruction is associated with diminished or stopped flow of luminal contents. Strangulating obstruction is associated with impaired blood flow to the duodenum in addition to obstructed flow of luminal contents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrara, F | 1 |
| Renzulli, A | 1 |
| Porreca, GP | 1 |
| Catalano, A | 1 |
| Spezzano, L | 1 |
| Arciprete, P | 1 |
1 other study available for prazosin and Duodenal Obstruction
| Article | Year |
|---|---|
[Mesenteric syndrome following the repair of aortic coarctation. Pathogenetic and clinical findings].
Topics: Adolescent; Adult; Aortic Coarctation; Child; Child, Preschool; Duodenal Obstruction; Female; Heart | 1981 |